1. Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health-Syst Pharm. 2002;59(11):1067-1076.
2. Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of "club drugs." Subst Use Misuse. 2005;40(9-10):1189-1201.
3. Rimsza ME, Moses KS. Substance abuse on the college campus. Pediatr Clin North Am. 2005;52(1):307-319.
4. Rome ES. It's a rave new world: rave culture and illicit drug use in the young. Cleve Clin J Med. 2001;68(6):541-550.
5. Jones CM, Clayton HB, Deputy NP, et al. Youth Risk Behavior Surveillance—United States, 2019. MMWR. 2020;69(Suppl-1):40-46.
6. American Addiction Centers. Ecstasy Statistics and History. Available athttps://drugabuse.com/drugs/ecstasy/history-statistics. Last accessed November 22, 2024.
7. Monitoring the Future. Marijuana Use is Rising; Ecstasy Use is Beginning to Rise; and Alcohol Use is Declining Among U.S. Teens. Available athttps://monitoringthefuture.org/wp-content/uploads/2021/02/10drugpr_complete.pdf. Last accessed November 25, 2024.
9. Greene JP, Ahrendt D, Stafford EM. Adolescent abuse of other drugs. Adolesc Med Clin. 2006;17(2):283-318.
10. Substance Abuse and Mental Health Services Administration. The DAWN Report: Ecstasy-Related Emergency Department Visits by Young People Increased Between 2005 and 2011; Alcohol Involvement Remains a Concern. Available athttps://www.samhsa.gov/data/sites/default/files/spot127-youth-ecstasy-2013/spot127-youth-ecstasy-2013.pdf. Last accessed November 22, 2024.
11. United Nations Office on Drugs and Crime. World Drug Report 2024. Available athttps://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html. Last accessed November 22, 2024.
13. National Institute on Drug Abuse. MDMA (Ecstasy/Molly). Available athttps://nida.nih.gov/research-topics/mdma-ecstasy-molly. Last accessed November 21, 2024.
14. National Drug Intelligence Center, Drug Enforcement Administration, United States Customs Service. Joint Assessment of MDMA Trafficking Trends. Johnstown, PA: National Drug Intelligence Center; 2000.
15. Sacco LN, Finklea K. Synthetic Drugs: Overview and Issues for Congress. Available athttps://sgp.fas.org/crs/misc/R42066.pdf. Last accessed November 25, 2024.
16. Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol. 2015;5(2):97-132.
18. LexiDrug. Available athttps://online.lexi.com. Last accessed November 25, 2024.
19. 19. Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med. 2009;6(4):1072-1080.
20. Hahn I-H. MDMA Toxicity. Available athttps://emedicine.medscape.com/article/821572-overview. Last accessed November 25, 2024.
21. Andresen H, Aydin BE, Mueller A, Iwersen-Bergmann S. An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results. Drug Test Anal. 2011;3(9):560-568.
22. U.S. Drug Enforcement Administration. Drug Fact Sheet: GHB. Available athttps://www.dea.gov/sites/default/files/2020-06/GHB-2020_0.pdf. Last accessed November 25, 2024.
23. Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate-a drug of abuse. Acta Neurol Scand. 2006;114(3):145-156.
24. Pardi D, Black J. Gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs. 2006;20(12):993-1018.
25. 25. Benzer TI. Gamma-Hydroxybutyrate Toxicity. Available athttps://emedicine.medscape.com/article/820531-overview. Last accessed November 25, 2024.
26. van Noorden MS, Kamal R, de Jong CA, Vergouwen AC, Zitman FG. Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment. Ned Tijdschr Geneeskd. 2010;154:A1286.
27. Kamal RM, Schellekens A, De Jong Ca, Dijkstra BA. Baclofen as relapse prevention in the treatment of Gamma-Hydroxybutyrate (GHB) dependence: an open label study. BMC Psychiatry. 2015;15:91.
28. Li JH, Vicknasingam B, Cheung YW, et al. To use or not to use: an update on licit and illicit ketamine use. Subst Abuse Rehabil. 2011;2:11-20.
29. Rega PP. Hallucinogen Toxicity Treatment and Management. Treatment: Prehospital Care. Available athttps://emedicine.medscape.com/article/814848-treatment. Last accessed November 25, 2024.
30. U.S. Drug Enforcement Administration. DEA Drug Fact Sheet: Rohypnol. Available athttps://www.dea.gov/factsheets/rohypnol. Last accessed November 25, 2024.
31. U.S. Drug Enforcement Administration. Drugs of Abuse: A DEA Resource Guide, 2017 Edition. Available athttps://www.dea.gov/sites/default/files/drug_of_abuse.pdf. Last accessed November 25, 2024.
32. 32. Hall JA, Moore CBT. Drug-facilitated sexual assault: a review. J Forensic Leg Med. 2008;15(5):291-297.
33. Basheer C. Recent analytical strategies on "date-rape" drugs and its metabolites. J App Pharm Sci. 2011;1(6):21-28.
34. Brisset C, Leanza Y, Laforest K. Working with interpreters in health care: a systematic review and meta-ethnography of qualitative studies. Patient Educ Couns. 2013;91(2):131-140.
35. Hwa-Froelich DA, Westby CE. Considerations when working with interpreters. Commun Disord Q. 2003;24(2): 78-85.
36. Lynch EW. Developing cross-cultural competence. In: Lynch EW, Hanson MJ (eds). A Guide for Working with Children and Their Families: Developing Cross-Cultural Competence. 3rd ed. Baltimore, MD: Paul H. Brookes Publishing Co.; 2004.
38. U.S. Drug Enforcement Administration. Gamma Hydroxybutyric Acid. Available athttps://www.deadiversion.usdoj.gov/drug_chem_info/ghb.pdf. Last accessed November 25, 2024.
39. U.S. Drug Enforcement Administration. 2024 National Drug Threat Assessment (NDTA) Summary. Available athttps://www.dea.gov/sites/default/files/2024-05/5.23.2024%20NDTA-updated.pdf. Last accessed November 22, 2024.
40. Monitoring the Future. National Survey Results on Drug Use,1975--2023 Overview and Detailed Results for Secondary Students. Available athttps://monitoringthefuture.org/wp-content/uploads/2024/01/mtfoverview2024.pdf. Last accessed November 21, 2024.
41. U.S. Department of Health and Human Services. Trends in the Prevalence of Marijuana, Cocaine, and Other Illegal Drug Use National YRBS: 1991–2023. Available at https://yrbs-explorer.services.cdc.gov/#/graphs?questionCode=H54&topicCode=C03&location=XX&year=2023. Last accessed November 21, 2024.
42. UK Home Office. Circular 001/2022: Reclassification of GHB and related substances. Available athttps://www.gov.uk/government/publications/circular-0012022-reclassification-of-ghb-and-related-substances/circular-0012022-reclassification-of-ghb-and-related-substances. Last accessed November 22, 2024.
43. Substance Abuse and Mental Health Services Administration. 2023 National Survey on Drug Use and Health: Detailed Tables. Available at https://www.samhsa.gov/data/report/2023-nsduh-detailed-tables. Last accessed November 21, 2024.
44. Substance Abuse and Mental Health Services Administration. Findings from Drug-Related Emergency Department Visits, 2021. Available at https://store.samhsa.gov/sites/default/files/pep22-07-03-002.pdf. Last accessed November 21, 2024.
45. Lykos Theraputics. Lykos Therapeutics Announces Complete Response Letter for Midomafetamine Capsules for PTSD. Available at https://news.lykospbc.com/2024-08-09-Lykos-Therapeutics-Announces-Complete-Response-Letter-for-Midomafetamine-Capsules-for-PTSD. Last accessed November 22, 2024.
46. van Amsterdam JG, van Laar M, Brunt TM, van den Brink W. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. Regul Toxicol Pharmacol. 2012;63(1):55-63.
47. Hill A. Ketamine Statistics On Use and Abuse. Available at https://www.addictiongroup.org/resources/ketamine-statistics/. Last accessed November 22, 2024.
48. Karabatur D. The Ketamine Boom: How the Wealthy are Getting Their Hands on the In-Demand Drug. Available at https://www.latimes.com/california/newsletter/2024-05-30/the-ketamine-boom-how-the-wealthy-are-getting-their-hands-on-the-in-demand-drug-essential-california. Last accessed November 22, 2024.
Mention of commercial products does not indicate endorsement.